ITGB1 and gastric cancer: Kaplan–Meier analysis showed that higher co-expression of CD29 and CD90 was correlated with worse disease-free survival (DFS) (stage I–III GC patients) and overall survival (OS) (stage IV GC patients) (Fig. 1k, l).